These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17510312)

  • 1. Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles.
    de Maat MF; Umetani N; Sunami E; Turner RR; Hoon DS
    Mol Cancer Res; 2007 May; 5(5):461-71. PubMed ID: 17510312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation.
    Umetani N; de Maat MF; Sunami E; Hiramatsu S; Martinez S; Hoon DS
    Mol Cancer Res; 2006 May; 4(5):303-9. PubMed ID: 16687485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
    de Maat MF; van de Velde CJ; van der Werff MP; Putter H; Umetani N; Klein-Kranenbarg EM; Turner RR; van Krieken JH; Bilchik A; Tollenaar RA; Hoon DS
    J Clin Oncol; 2008 May; 26(14):2327-35. PubMed ID: 18467724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of repulsive guidance molecule member A by DNA methylation in colorectal cancer is related to tumor progression.
    Zhao ZW; Lian WJ; Chen GQ; Zhou HY; Wang GM; Cao X; Yang HJ; Hou YP
    Oncol Rep; 2012 May; 27(5):1653-9. PubMed ID: 22367090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
    Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
    Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time PCR-based assay for quantitative determination of methylation status.
    Lehmann U; Kreipe H
    Methods Mol Biol; 2004; 287():207-18. PubMed ID: 15273414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors.
    Ally MS; Al-Ghnaniem R; Pufulete M
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
    Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
    Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors.
    Hashimoto K; Shimizu Y; Suehiro Y; Okayama N; Hashimoto S; Okada T; Hiura M; Ueno K; Hazama S; Higaki S; Hamanaka Y; Oka M; Sakaida I; Hinoda Y
    Mol Carcinog; 2008 Jan; 47(1):1-8. PubMed ID: 17620311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantification of methylation of SNCG CpG islands in human tissue samples by the combined COBRA-DHPLC assay].
    Zhou J; Wen XZ; Deng DJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():20-4. PubMed ID: 17767852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.